Related Experiment Video
Updated: Mar 29, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.5K
Frontotemporal Dementia.
Roger E Kelley1, Ramy El-Khoury1
1Department of Neurology, Tulane University School of Medicine, 1430 Tulane Avenue, 8065, New Orleans, LA 70112, USA.
Neurologic Clinics
|November 29, 2015
Summary
Frontotemporal dementia (FTD) is a progressive cognitive decline often linked to genetic factors. It presents as a spectrum of brain pathologies, distinct from Alzheimer disease, with early behavioral or language symptoms.
Area of Science:
- Neuroscience
- Neurology
- Genetics
Background:
- Frontotemporal dementia (FTD) is a significant cause of progressive cognitive impairment.
- Genetic susceptibility is often observed in patients with FTD.
- FTD represents a spectrum of neuropathological processes, not a single mechanism.
Purpose of the Study:
- To elucidate the diverse pathological mechanisms underlying Frontotemporal dementia.
- To differentiate FTD from other neurodegenerative conditions like Alzheimer disease.
- To characterize the early manifestations and subcategories of FTD.
Main Methods:
- Review of existing literature on FTD.
- Analysis of neuropathological findings in FTD cases.
- Clinical assessment of patient presentations.
Main Results:
- FTD involves pathologies primarily affecting the frontal and temporal lobes.
- FTD typically has an earlier onset compared to Alzheimer disease.
- Key FTD variants include behavioral and language-predominant forms (primary progressive aphasia).
Conclusions:
- FTD is a complex neurodegenerative syndrome with varied underlying pathologies.
- Early recognition of behavioral or communication changes is crucial for FTD diagnosis.
- Understanding FTD subtypes aids in targeted research and clinical management.
Related Concept Videos
01:30Dementia
702
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
702
01:21Association Areas of the Cortex
10.5K
Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
10.5K
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:24Prosopagnosia
1.1K
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
1.1K
01:14Role of Cerebellum and Prefrontal Cortex in Memory
1.4K
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
1.4K